Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

Avax evaluates its ovarian cancer vaccine in phase II

Oct. 20, 1997

New GVAX cancer vaccine begins human testing

Oct. 17, 1997

Jenner Technologies initiates clinical testing of AdjuVax-100a

Oct. 16, 1997

Meeting of Biological Response Modifiers Advisory Committee this week

Oct. 14, 1997

Cancer cells being used to treat cancer

Oct. 13, 1997

Phase II results for IDEC-C2B8 in NHL

Oct. 13, 1997

Preliminary results from study of MultiKine in head and neck cancer patients

Oct. 9, 1997

Genentech returns rights to IDEC-Y2B8 to IDEC

Oct. 6, 1997

IL-2 + IFN-alpha in phase II for renal cell carcinoma

Oct. 1, 1997

Techniclone submits IND for malignant glioma

Sep. 30, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...